Telum Therapeutics Secures €18 Million Series A Financing to Advance Lead Antimicrobial Program into Clinical Development

by Telum Therapeutics

12 days ago
Telum Therapeutics, Inveready, Sodena, Invivo Partners, Clave Capital, CDTI, AMR Action Fund, Acinetobacter baumannii

Telum Therapeutics, a biotechnology company leveraging proprietary metagenomic datasets, synthetic biology and generative AI to develop novel antimicrobial therapies, has announced the successful comp...

InnoUp Farma, backed by Sodena, Successfully Completes Phase 1 Trial of INP20, Its Innovative Oral Immunotherapy for Peanut Allergy

by Sodena

18 days ago
Food Allergy Treatment, Sodena, INP20, InnoUp Farma

Unlike other therapies currently available or under development, INP20 is not designed to desensitise patients to the allergen. Instead, it aims to replicate the biological signals generated by the gu...

Navarra proyecta el Plan Empresarial de Biología Sintética ‘BioSintNa’, liderado por Sodena, con 65 acciones estratégicas

by Sodena

1 year ago
biología sintética, Sodena, BioSintNA

BioSintNA incluirá en su formulación acciones de promoción y visibilidad, formación y talento, fomento y desarrollo del tejido empresarial, regulación y ética, sostenibilidad del modelo de negoc...

Medibiofarma obtiene un millón de euros para impulsar la Fase Clínica de sus tres fármacos

by Medibiofarma

2 years ago
Medibiofarma, Sodena, Inveready

Medibiofarma, empresa biofarmacéutica navarra que se dedica a descubrir y desarrollar nuevas terapias para enfermedades de alta necesidad médica, ha cerrado una ronda de financiación por valor de u...

Palobiofarma closes a €7M round with the participation of Inveready, Sodena and the Promotor team

by Palobiofarma

2 years ago
Palobiofarma, Sodena, Inveready

The investment will be used to complete three phase II clinical trials in which the efficacy of its most advanced products is being studied, namely PBF-680 in patients with chronic obstructive pulmona...

SciClone joins the capital of AbilityPharma, supported by Inveready, Fitalent, Sodena and the CDTI, with an investment commitment of $3 million

by AbilityPharma

6 years ago
AbilityPharma, SciClone, Inveready, CDTI, Sodena

Carles Domènech, Executive Chairman, Chief Scientific Officer and Co-Founder of AbilityPharma, said: "We are very happy to have reached this agreement with SciClone. This investment represents a cont...

AbilityPharma awarded €5 million from the Horizon Europe EIC Accelerator Pilot Program to conduct a Phase 2b clinical trial with ABTL0812 in patients with advanced pancreatic cancer

by AbilityPharma

6 years ago
Inveready, Everis, Sodena, Ability Pharma, BEI, drug, financing, PancreaticCancer

The biopharmaceutical company Ability Pharmaceuticals SL announced today that it has been awarded €5 million blended financing from the Horizon Europe, European Innovation Council (EIC) Accelerator ...

Sodena e Inveready invierten en la biotecnológica InnoUp Farma

by Inveready

11 years ago
InnoUp Farma, Inveready, Sodena, Inveready Innvierte Biotech II

La compañía ha conseguido 2 millones de euros de Sodena, Inveready y el Ministerio de Economía y Competitividad. La compañía se dedica a la innovación nanotecnológica dirigida al desarrollo de ...